Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Hashimoto

Showing results (261-270 of 330) with videos related to

Pageof 33
Sort By:
Urologia Internationalis|December 3, 2020
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion ProjectSakae Konishi, Shingo Hatakeyama, Atsushi Imai, et al.
Fukushima Journal of Medical Science|August 10, 2021
Total transferrin in cerebrospinal fluid is a novel biomarker for spontaneous intracranial hypotensionJunko Iijima, Kyoka Hoshi, Hiromi Ito, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 27, 2020
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancerKazutaka Okita, Shingo Hatakeyama, Masaki Momota, et al.
World Journal of Urology|December 15, 2022
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective studyKai Ozaki, Shingo Hatakeyama, Shintaro Narita, et al.
BJU International|September 15, 2018
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in JapanTeppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, et al.
BJU International|January 23, 2021
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective studyTomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, et al.
European Urology Focus|July 30, 2017
Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial CarcinomaMasaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, et al.
Medical Oncology (Northwood, London, England)|February 27, 2018
Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomyHirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, et al.
Translational Andrology and Urology|April 14, 2021
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)Hiromichi Iwamura, Shingo Hatakeyama, Masaki Momota, et al.
Urologic Oncology|April 18, 2021
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinomaKazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, et al.
Pageof 33

Showing results (261-270 of 330) with videos related to

Sort By:
Pageof 33
Urologia Internationalis|December 3, 2020
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion ProjectSakae Konishi, Shingo Hatakeyama, Atsushi Imai, et al.
Fukushima Journal of Medical Science|August 10, 2021
Total transferrin in cerebrospinal fluid is a novel biomarker for spontaneous intracranial hypotensionJunko Iijima, Kyoka Hoshi, Hiromi Ito, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 27, 2020
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancerKazutaka Okita, Shingo Hatakeyama, Masaki Momota, et al.
World Journal of Urology|December 15, 2022
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective studyKai Ozaki, Shingo Hatakeyama, Shintaro Narita, et al.
BJU International|September 15, 2018
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in JapanTeppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, et al.
BJU International|January 23, 2021
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective studyTomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, et al.
European Urology Focus|July 30, 2017
Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial CarcinomaMasaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, et al.
Medical Oncology (Northwood, London, England)|February 27, 2018
Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomyHirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, et al.
Translational Andrology and Urology|April 14, 2021
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)Hiromichi Iwamura, Shingo Hatakeyama, Masaki Momota, et al.
Urologic Oncology|April 18, 2021
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinomaKazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, et al.
Pageof 33